SCHEMBL30399451

SCHEMBL30399451

Cc1ccccc1-c1cnc2[nH]ccc2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 8/20 0.64
AXL P30530 1/20 0.64
NUDT1 P36639 1/20 0.56
DHFR P00374 1/20 0.54
PIK3CA P42336 2/20 0.54
PIK3CD O00329 1/20 0.54
PIK3CB P42338 1/20 0.54
PIK3CG P48736 1/20 0.54
RIPK1 Q13546 2/20 0.53
PLK4 O00444 1/20 0.51
DCLK1 O15075 1/20 0.51
ROCK2 O75116 1/20 0.51
PRKD3 O94806 1/20 0.51
MAP4K4 O95819 1/20 0.51
PAK4 O96013 1/20 0.51
CHEK2 O96017 1/20 0.51
INSR P06213 1/20 0.51
CDK1 P06493 1/20 0.51
FES P07332 1/20 0.51
ROS1 P08922 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL858328 1.00 CDK8 (0.64) CDK8AXLNUDT1DHFRPIK3CA
SCHEMBL20627463 0.88 ALOX5AP (0.68) CDK8AXLALOX5APFEN1
SCHEMBL13854162 0.88 CDK8 (0.56) CDK8AXLNUDT1DHFRPIK3CA
SCHEMBL13854156 0.83 DHFR (0.56) CDK8AXLNUDT1DHFRPIK3CA
SCHEMBL15730259 0.82 FEN1 (0.57) CDK8AXLNUDT1DHFRPIK3CA
SCHEMBL31064990 0.81 CDK8 (0.64) CDK8AXLNUDT1PIK3CAPIK3CD
SCHEMBL858203 0.81 CDK8 (0.64) CDK8AXLNUDT1PIK3CAPIK3CD
SCHEMBL858609 0.81 AXL (0.64) CDK8AXLNUDT1PIK3CAPIK3CD
SCHEMBL12127568 0.81 CDK8 (0.64) CDK8AXLNUDT1DHFRPIK3CA
SCHEMBL13854545 0.81 DHFR (0.54) CDK8AXLNUDT1DHFRPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4415817-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BioSplice Therapeutics, Inc. (US) 2024-08-21 EP claimed
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2023-06-22 US claimed
WO-2023064349-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BIOSPLICE THERAPEUTICS, INC. (US) 2023-04-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 CDK8 485/4885AXL 1433/4885NUDT1 3188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.